Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

dr amanda kerr

dr amanda kerr

Amanda Kerr

PhD


Postdoctoral Epidemiologist

Amanda Kerr joined CTSU as a research assistant with the Early Breast Cancer Trialists’ Collaborative Group in 2008. She went on to complete a PhD with Sarah Darby, investigating the cardiotoxic effects of anthracycline chemotherapy, graduating in 2016. Amanda works in the Late Effects team working on systematic reviews of long term outcomes of cancer treatments.